Back to AMLX
D. E. Shaw & Co., Inc. AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$2.2M
Q2 2026
Peak value
$51.1M
First seen
Q3 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2022 | $4.6M |
| Q4 2022 | $51.1M |
| Q4 2023 | $3.3M |
| Q4 2023 | $4.7M |
| Q1 2024 | $1.7M |
| Q1 2024 | $1.3M |
| Q2 2024 | $1.3M |
| Q2 2024 | $1.2M |
| Q3 2024 | $1.3M |
| Q3 2024 | $960K |
| Q4 2024 | $491K |
| Q4 2024 | $669K |
| Q1 2025 | $627K |
| Q1 2025 | $329K |
| Q2 2025 | $316K |
| Q2 2025 | $655K |
| Q3 2025 | $936K |
| Q4 2025 | $885K |
| Q1 2026 | $557K |
| Q1 2026 | $475K |
| Q2 2026 | $979K |
| Q2 2026 | $2.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $2.2M | 119.7K | — | — |
| Q2 2026 | $979K | 54.5K | — | — |
| Q1 2026 | $475K | 34.1K | — | — |
| Q1 2026 | $557K | 40.1K | — | — |
| Q4 2025 | $885K | 73.2K | — | — |
| Q3 2025 | $936K | 68.9K | — | — |
| Q2 2025 | $655K | 102.2K | — | — |
| Q2 2025 | $316K | 49.3K | — | — |
| Q1 2025 | $329K | 93.0K | — | — |
| Q1 2025 | $627K | 177.0K | — | — |
| Q4 2024 | $669K | 176.9K | — | — |
| Q4 2024 | $491K | 129.9K | — | — |
| Q3 2024 | $960K | 296.3K | — | — |
| Q3 2024 | $1.3M | 394.8K | — | — |
| Q2 2024 | $1.2M | 609.9K | — | — |
| Q2 2024 | $1.3M | 698.3K | — | — |
| Q1 2024 | $1.3M | 454.7K | — | — |
| Q1 2024 | $1.7M | 587.9K | — | — |
| Q4 2023 | $4.7M | 320.3K | — | — |
| Q4 2023 | $3.3M | 226.7K | — | — |
| Q4 2022 | $51.1M | 1.38M | — | — |
| Q3 2022 | $4.6M | 162.3K | — | — |